Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Detalles Bibliográficos
Autores principales: Mariottini, Alice, Repice, Anna Maria, Barilaro, Alessandro, Massacesi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940562/
https://www.ncbi.nlm.nih.gov/pubmed/35318561
http://dx.doi.org/10.1007/s10072-022-05961-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940562/
https://www.ncbi.nlm.nih.gov/pubmed/35318561
http://dx.doi.org/10.1007/s10072-022-05961-9

Ejemplares similares